| Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes TH Julian, N Glascow, ADF Barry, T Moll, C Harvey, YC Klimentidis, ... EBioMedicine 68, 2021 | 108 | 2021 |
| Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis S Zhang, J Cooper-Knock, AK Weimer, M Shi, T Moll, JNG Marshall, ... Neuron 110 (6), 992-1008. e11, 2022 | 94 | 2022 |
| Disrupted glycosylation of lipids and proteins is a cause of neurodegeneration T Moll, PJ Shaw, J Cooper-Knock Brain 143 (5), 1332-1340, 2020 | 80 | 2020 |
| Mutations in the glycosyltransferase domain of GLT8D1 are associated with familial amyotrophic lateral sclerosis J Cooper-Knock, T Moll, T Ramesh, L Castelli, A Beer, H Robins, I Fox, ... Cell reports 26 (9), 2298-2306. e5, 2019 | 73 | 2019 |
| A review of Mendelian randomization in amyotrophic lateral sclerosis TH Julian, S Boddy, M Islam, J Kurz, KJ Whittaker, T Moll, C Harvey, ... Brain 145 (3), 832-842, 2022 | 53 | 2022 |
| Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene J Cooper-Knock, S Zhang, KP Kenna, T Moll, JP Franklin, S Allen, ... Cell Reports 33 (9), 2020 | 26 | 2020 |
| Membrane lipid raft homeostasis is directly linked to neurodegeneration T Moll, JNG Marshall, N Soni, S Zhang, J Cooper-Knock, PJ Shaw Essays in Biochemistry 65 (7), 999-1011, 2021 | 25 | 2021 |
| Advances in the genetic classification of amyotrophic lateral sclerosis J Cooper-Knock, C Harvey, S Zhang, T Moll, IS Timpanaro, KP Kenna, ... Current opinion in neurology 34 (5), 756-764, 2021 | 21 | 2021 |
| Simultaneous ALS and SCA2 associated with an intermediate-length ATXN2 CAG-repeat expansion H Ghahremani Nezhad, JP Franklin, JJP Alix, T Moll, M Pattrick, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22 (7-8), 579-582, 2021 | 18 | 2021 |
| Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene J Cooper-Knock, S Zhang, KP Kenna, T Moll, JP Franklin, S Allen, ... Cell Reports 34 (5), 2021 | 14 | 2021 |
| Preclinical models of disease and multimorbidity with focus upon cardiovascular disease and dementia O Shabir, TA Moll, MM Matuszyk, B Eyre, MD Dake, J Berwick, SE Francis Mechanisms of Ageing and Development 192, 111361, 2020 | 14 | 2020 |
| Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes. EBioMedicine 68: 103397 TH Julian, N Glascow, ADF Barry, T Moll, C Harvey, YC Klimentidis, ... J. EBIOM, 2021 | 11 | 2021 |
| Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis S Boddy, M Islam, T Moll, J Kurz, D Burrows, A McGown, A Bhargava, ... Brain Communications 4 (2), fcac069, 2022 | 10 | 2022 |
| Atypical TDP‐43 protein expression in an ALS pedigree carrying a p.Y374X truncation mutation in TARDBP J Cooper‐Knock, TH Julian, E Feneberg, JR Highley, M Sidra, MR Turner, ... Brain Pathology 33 (1), e13104, 2023 | 8 | 2023 |
| Stress-induced TDP-43 nuclear condensation causes splicing loss of function and STMN2 depletion WP Huang, BCS Ellis, RE Hodgson, AS Avila, V Kumar, J Rayment, T Moll, ... Cell Reports 43 (7), 2024 | 5 | 2024 |
| Concurrent sodium channelopathies and amyotrophic lateral sclerosis supports shared pathogenesis JP Franklin, J Cooper-Knock, A Baheerathan, T Moll, R Männikkö, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21 (7-8), 627-630, 2020 | 5 | 2020 |
| Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis C Harvey, M Weinreich, JAK Lee, AC Shaw, L Ferraiuolo, H Mortiboys, ... Heliyon 10 (3), 2024 | 4 | 2024 |
| Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication T Moll, V Odon, C Harvey, MO Collins, A Peden, J Franklin, E Graves, ... Life Science Alliance 6 (1), 2023 | 4 | 2023 |
| GLT8D1 mutations cause amyotrophic lateral sclerosis via disruption of neurotrophin signalling within membrane lipid rafts T Moll, E Graves, A Urbanek, N Soni, R Ranganathan, A Higginbottom, ... bioRxiv, 2022.06. 28.497990, 2022 | 4 | 2022 |
| Mitochondrial function determines severity but not risk of amyotrophic lateral sclerosis C Harvey, M Weinreich, S Zhang, PJ Hop, RAJ Zwamborn, K van Eijk, ... BioRxiv, 2022.05. 31.494229, 2022 | 2 | 2022 |
Johnathan Cooper-KnockClinical Fellow, University of Sheffield在 sheffield.ac.uk 的电子邮件经过验证
Johnathan Cooper-KnockClinical Fellow, University of Sheffield在 sheffield.ac.uk 的电子邮件经过验证
Pamela J ShawProfessor of Neurology, University of Sheffield在 sheffield.ac.uk 的电子邮件经过验证